These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21048784)

  • 41. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.
    Lan Q; Peyvandi S; Duffey N; Huang YT; Barras D; Held W; Richard F; Delorenzi M; Sotiriou C; Desmedt C; Lorusso G; Rüegg C
    Oncogene; 2019 Apr; 38(15):2814-2829. PubMed ID: 30546090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant radiotherapy trials in breast cancer.
    Stjernswärd J
    Cancer; 1977 Jun; 39(6 Suppl):2846-67. PubMed ID: 326382
    [No Abstract]   [Full Text] [Related]  

  • 44. What can be learnt about disease progression in breast cancer dormancy from relapse data?
    Willis L; Graham TA; Alarcón T; Alison MR; Tomlinson IP; Page KM
    PLoS One; 2013; 8(5):e62320. PubMed ID: 23671591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells.
    Shimizu H; Takeishi S; Nakatsumi H; Nakayama KI
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients.
    Borgen E; Rypdal MC; Sosa MS; Renolen A; Schlichting E; Lønning PE; Synnestvedt M; Aguirre-Ghiso JA; Naume B
    Breast Cancer Res; 2018 Oct; 20(1):120. PubMed ID: 30322396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The premise of personalized immunotherapy for cancer dormancy.
    Manjili MH
    Oncogene; 2020 May; 39(22):4323-4330. PubMed ID: 32322001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Adjuvant chemotherapy for breast cancer and targeted therapies].
    Dufresne A; Bachelot T; Blay JY
    Rev Prat; 2008 Mar; 58(5):477-8. PubMed ID: 18524101
    [No Abstract]   [Full Text] [Related]  

  • 49. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial.
    Harbeck N; Huang CS; Hurvitz S; Yeh DC; Shao Z; Im SA; Jung KH; Shen K; Ro J; Jassem J; Zhang Q; Im YH; Wojtukiewicz M; Sun Q; Chen SC; Goeldner RG; Uttenreuther-Fischer M; Xu B; Piccart-Gebhart M;
    Lancet Oncol; 2016 Mar; 17(3):357-366. PubMed ID: 26822398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen.
    Kontos M; Allen DS; Agbaje OF; Hamed H; Fentiman IS
    Eur J Surg Oncol; 2011 Dec; 37(12):1051-8. PubMed ID: 21843919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer of the breast. Local and regional recurrence.
    Donegan WL
    Major Probl Clin Surg; 1967; 5():190-200. PubMed ID: 5634183
    [No Abstract]   [Full Text] [Related]  

  • 53. How to Predict Metastasis in Luminal Breast Cancer? Current Solutions and Future Prospects.
    Tabor S; Szostakowska-Rodzos M; Fabisiewicz A; Grzybowska EA
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.
    Hanin L
    Adv Exp Med Biol; 2013; 734():261-82. PubMed ID: 23143983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth.
    Weidenfeld K; Schif-Zuck S; Abu-Tayeh H; Kang K; Kessler O; Weissmann M; Neufeld G; Barkan D
    Oncotarget; 2016 Nov; 7(44):71362-71377. PubMed ID: 27655685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.
    Raghavendra A; Sinha AK; Valle-Goffin J; Shen Y; Tripathy D; Barcenas CH
    Clin Breast Cancer; 2018 Feb; 18(1):e7-e13. PubMed ID: 29239836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trastuzumab for early breast cancer: current status and future directions.
    Dinh P; de Azambuja E; Piccart-Gebhart MJ
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):707-17. PubMed ID: 17982412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expert roundtable: emerging questions in ErbB2-positive breast cancer; February 22, 2007.
    Pegram M; Perez EA; Piccart M; Spector N
    Clin Breast Cancer; 2008 Mar; 8 Suppl 3():S131-41. PubMed ID: 18777952
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
    Schramm A; Friedl TW; Schochter F; Scholz C; de Gregorio N; Huober J; Rack B; Trapp E; Alunni-Fabbroni M; Müller V; Schneeweiss A; Pantel K; Meier-Stiegen F; Hartkopf A; Taran FA; Wallwiener D; Janni W; Fehm T
    Arch Gynecol Obstet; 2016 Feb; 293(2):271-81. PubMed ID: 26354331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.
    Clare SE; Nakhlis F; Panetta JC
    Breast Cancer Res; 2000; 2(6):430-5. PubMed ID: 11250737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.